BIOMAT Database Logo BIOMAT Database Logo

Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. 2011

R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Department of Virology, Erasmus Medical Center, Dr. Molewaterplein 50, P. O. Box 2040, 3000 CA Rotterdam, Netherlands.

Infection with seasonal influenza viruses induces a certain extent of protective immunity against potentially pandemic viruses of novel subtypes, also known as heterosubtypic immunity. Here we demonstrate that infection with a recent influenza A/H3N2 virus strain induces robust protection in ferrets against infection with a highly pathogenic avian influenza virus of the H5N1 subtype. Prior H3N2 virus infection reduced H5N1 virus replication in the upper respiratory tract, as well as clinical signs, mortality, and histopathological changes associated with virus replication in the brain. This protective immunity correlated with the induction of T cells that cross-reacted with H5N1 viral antigen. We also demonstrated that prior vaccination against influenza A/H3N2 virus reduced the induction of heterosubtypic immunity otherwise induced by infection with the influenza A/H3N2 virus. The implications of these findings are discussed in the context of vaccination strategies and vaccine development aiming at the induction of immunity to pandemic influenza.

UI MeSH Term Description Entries
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D009976 Orthomyxoviridae Infections Virus diseases caused by the ORTHOMYXOVIRIDAE. Orthomyxovirus Infections,Infections, Orthomyxoviridae,Infections, Orthomyxovirus,Swine Influenza,Infection, Orthomyxoviridae,Infection, Orthomyxovirus,Influenza, Swine,Orthomyxoviridae Infection,Orthomyxovirus Infection
D012137 Respiratory System The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. Respiratory Tract,Respiratory Systems,Respiratory Tracts,System, Respiratory,Tract, Respiratory
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D005289 Ferrets Semidomesticated variety of European polecat much used for hunting RODENTS and/or RABBITS and as a laboratory animal. It is in the subfamily Mustelinae, family MUSTELIDAE. Domestic Polecat,Domestic Polecats,European Polecat,European Polecats,Ferret,Mustela putorius,Mustela putorius furo,Polecat, Domestic,Polecat, European,Polecats, Domestic,Polecats, European
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination.
February 2010, Vaccine,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis.
March 2014, Journal of virology,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
December 2013, Journal of virology,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Repeated vaccination against matched H3N2 influenza virus gives less protection than single vaccination in ferrets.
January 2019, NPJ vaccines,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus.
March 2011, PloS one,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets.
January 2016, PloS one,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Induction of cross-neutralizing antibody against H5N1 virus after vaccination with seasonal influenza vaccine in COPD patients.
June 2010, Viral immunology,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Induction of heterosubtypic immunity to influenza virus by intranasal immunization.
February 2008, Journal of virology,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Seasonal trivalent inactivated influenza vaccine protects against 1918 Spanish influenza virus infection in ferrets.
July 2012, Journal of virology,
R Bodewes, and J H C M Kreijtz, and M M Geelhoed-Mieras, and G van Amerongen, and R J Verburgh, and S E van Trierum, and T Kuiken, and R A M Fouchier, and A D M E Osterhaus, and G F Rimmelzwaan
Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets.
April 2011, Vaccine,
Copied contents to your clipboard!